Conditions: Psoriasis Vulgaris
Keywords: Psoriasis Vulgaris Systemic Anti-psoriatic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 63
Healthy volunteers: no

Brief summary:
An international, multi-centre, prospective, randomised, double-blind, 4-arm, placebo controlled, parallel group study with 12 weeks once daily oral treatment in subjects with psoriasis vulgaris.

Detailed description:

Arms:
arm 1: LEO 22811 0.5 mg: Oral solution arm 2: LEO 22811 1.5 mg: Oral solution arm 3: LEO 22811 3.0 mg: Oral solution arm 4: Placebo: Oral solution

Interventions: intervention 1: LEO 22811 intervention 2: Placebo
Intervention descriptions: intervention 1: Oral solution intervention 2: Placebo

Protocol document: